Chad vs Turkmenistan: Tuberculosis treatment success rate
Chad
84.0%
in 2023
Turkmenistan
84.0%
in 2023
Chad rank
96th
Turkmenistan rank
96th
Tuberculosis treatment success rate over time
- Chad
- Turkmenistan
How they compare
Chad currently reports 84.0% against 84.0% in Turkmenistan, a difference of 0.0%.
The two have swapped places 6 times across 19 shared years of data; in 2002 it was Turkmenistan ahead.
Chad ranks 96th and Turkmenistan ranks 96th of 203 countries.
Turkmenistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chad | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 65.8% | 82.0% | 16.2% | Turkmenistan |
| 2010s | 72.1% | 83.7% | 11.6% | Turkmenistan |
| 2020s | 82.5% | 83.0% | 0.5% | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate, Chad or Turkmenistan?
- Chad, at 84.0% against 84.0% in Turkmenistan as of 2023.
- What is the difference in tuberculosis treatment success rate between Chad and Turkmenistan?
- 0.0%, with Chad ahead.
- How many years of comparable data are there for Chad and Turkmenistan?
- 19 years are reported by both, from 2002 to 2023.
- How do Chad and Turkmenistan rank globally for tuberculosis treatment success rate?
- Chad ranks 96th and Turkmenistan ranks 96th of 203 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Tuberculosis treatment success rate (% of new cases). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Tuberculosis treatment success rate is the percentage of all new tuberculosis cases (or new and relapse cases for some countries) registered under a national tuberculosis control programme in a given year that successfully completed treatment, with or without bacteriological evidence of success ("cured" and "treatment completed" respectively).